Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Testosterone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR known ✓ | P10275 | 4/20 | 0.75 |
| ▸ | LMNA | P02545 | 8/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.75 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.75 |
| ▸ | TSHR | P16473 | 5/20 | 0.75 |
| ▸ | MAPT | P10636 | 5/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.75 |
| ▸ | SHBG | P04278 | 4/20 | 0.75 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.75 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.75 |
| ▸ | PGR | P06401 | 4/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.75 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.75 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.75 |
| ▸ | SNCA | P37840 | 2/20 | 0.75 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.75 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.75 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Testosterone SCHEMBL5082498 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL5080100 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL5078098 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL1087216 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL5078860 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL2023832 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Behenic Acid SCHEMBL11429128 | 1.00 | LMNA (0.75) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL14694449 | 0.99 | LMNA (0.77) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL14694321 | 0.96 | LMNA (0.78) | LMNACYP3A4CYP19A1TSHRMAPT | |
| Testosterone SCHEMBL8075829 | 0.95 | LMNA (0.83) | LMNACYP3A4CYP19A1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4389 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629483-B2 | Syringe shock absorber for use in an injection device | ANTARES PHARMA, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260034313-A1 | SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE | ANTARES PHARMA, INC. (US) | 2026-02-05 | — | — | US | claimed |
| US-20260034302-A1 | Needle Assisted Injection Device Having Reduced Trigger Force | ANTARES PHARMA, INC. (US) | 2026-02-05 | — | — | US | claimed |
| US-12527802-B2 | Administration of testosterone compositions | ANTARES PHARMA, INC. (US) | 2026-01-20 | — | — | US | claimed |
| WO-2025227129-A2 | DELIVERY VEHICLES COMPRISING PROGLUCAGON DERIVED POLYPEPTIDES AND ANABOLIC POLYPEPTIDES AND USES THEREOF | STARROCK PHARMA LLC (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250325560-A1 | METHODS FOR IMPROVING MUSCLE MASS, STRENGTH, OR FUNCTION WITH A COMBINATION OF TESTOSTERONE AND GROWTH HORMONE | UNIVERSITY OF ROCHESTER (US) | 2025-10-23 | — | — | US | claimed |
| US-20250281509-A1 | SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER | THE JOHNS HOPKINS UNIVERSTY | 2025-09-11 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-12310928-B2 | Enthesis healing | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2025-05-27 | — | — | US | claimed |
| WO-1994026207-A1 | METHODS AND FORMULATIONS FOR USE IN TREATING BENIGN GYNECOLOGICAL DISORDERS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1994-11-24 | — | — | WO | claimed |
| US-5340585-A | Administering slow release formulation of gonadotropin hormone releasing hormone and estrogen | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1994-08-23 | — | — | US | claimed |
| US-5340584-A | Gonadotropin hormone releasing hormone, an estrogenic composition and a progestogen | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1994-08-23 | — | — | US | claimed |
| US-5340586-A | Methods and formulations for use in treating oophorectomized women | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1994-08-23 | — | — | US | claimed |
| EP-0538443-A4 | METHODS AND FORMULATIONS FOR USE IN INHIBITING CONCEPTION AND IN TREATING BENIGN GYNECOLOGICAL DISORDERS | — | 1993-12-08 | — | — | EP | claimed |
| EP-0538443-A1 | METHODS AND FORMULATIONS FOR USE IN INHIBITING CONCEPTION AND IN TREATING BENIGN GYNECOLOGICAL DISORDERS. | UNIV SOUTHERN CALIFORNIA (US) | 1993-04-28 | — | — | EP | claimed |
| WO-1992018107-A1 | METHODS AND FORMULATIONS FOR USE IN INHIBITING CONCEPTION AND IN TREATING BENIGN GYNECOLOGICAL DISORDERS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0479867-A1 | COMPOSITIONS USEFUL AS CONTRACEPTIVES IN MALES. | COHEN MICHAEL (NL) | 1992-04-15 | — | — | EP | claimed |
| WO-1991000095-A1 | COMPOSITIONS USEFUL AS CONTRACEPTIVES IN MALES | COHEN MICHAEL (NL) | 1991-01-10 | — | — | WO | claimed |
| US-4008311-A | HEXESTROL DICAPRYLATE, TESTOSTERONE ENANTHATE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-02-15 | — | — | US | claimed |